Institut Za Proučavanje Lekovitog Bilja "Dr Josif Pančić"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Za Proučavanje Lekovitog Bilja "Dr Josif Pančić"filedCriticalInstitut Za Proučavanje Lekovitog Bilja "Dr Josif Pančić"
Priority to RS20080024ApriorityCriticalpatent/RS52749B/en
Publication of RS20080024ApublicationCriticalpatent/RS20080024A/en
Publication of RS52749BpublicationCriticalpatent/RS52749B/en
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
Medicines Containing Plant Substances
(AREA)
Compounds Of Unknown Constitution
(AREA)
Abstract
Fitopreparat, naznačeni time, što sadrži izolat korena Carlina acanthifolia - etarsko ulje sa dominantnom komponentom benzil 2-furilacetilen ili karlina-oksid zastupljen u količini preko 91% u obliku hidrofilnog krema i rastvora za primenu u terapijske svrhe.Prijava sadrži još 1 nezavisni i 5 zavisnih patentnih zahteva.Phytopreparation, indicated by the fact that it contains an isolate of the roots of Carlina acanthifolia - essential oil with the dominant component benzyl 2-furylacetylene or carline-oxide represented in an amount of more than 91% in the form of a hydrophilic cream and solution for use for therapeutic purposes. The application contains another 1 independent and 5 dependent patent claims.
RS20080024A2008-01-172008-01-17Phytopreparations with isolates of stemless carline thistle root
RS52749B
(en)
Use of compound genz-112638 (eliglustat), glucosylceramide synthase inhibitor, in the treatment of gaucher disease and fabry disease (divisional application 201201348).
use of a composition, thickener composition of nutritional products, thickened nutritional product, and method for preparing a thickened nutritional product
oral health improvement compositions, method of using a composition and use of at least one beneficial bacterium for the preparation of an oral health improvement composition